ClinicalTrials.gg
CompletedNCT02962505CRADLUpdated Mar 21, 2019

Continuous Regional Analysis Device for Neonate Lung

An observational study in Infant Respiratory Distress Syndrome, Acute Bronchiolitis and Acute Respiratory Distress Syndrome, sponsored by University Hospital Schleswig-Holstein. Completed at 4 sites in 3 countries. Open to participants aged Up to 7 Years. Per ClinicalTrials.gov, last updated 2019-03-21.

Sponsored by University Hospital Schleswig-Holstein · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
200
Ages
Up to 7 Years
Sex
All
01

Study summary

The purpose of the study is to assess whether Electrical Impedance Tomography (EIT) has the potential to optimize the ventilator therapy, validate the effectiveness, efficacy and safety of nursing and medical interventions (endotracheal suctioning, posture changes, surfactant therapy, recruitment manoeuvres, etc.) and for early recognition of complications like pneumothorax and endotracheal tube misplacement. The study design is purely observational.

Read the detailed description

EIT data will be recorded during 72 hours of routine clinical treatment. To prevent any decisions based on EIT information, the clinicians will be blinded to the EIT findings during the study period. Data on clinical interventions and clinical findings will be recorded using a specially adapted graphical user interface on the EIT device in combination with a paper-based case report form (CRF). EIT data analysis will be performed off-line.

02

Conditions studied

  • Infant Respiratory Distress Syndrome
  • Acute Bronchiolitis
  • Acute Respiratory Distress Syndrome
03

In context

Pulmonary Atelectasis

308 studies on the registry are indexed under Pulmonary Atelectasis; 79 are open to participants now.

This study's enrollment of 200 is above the median of 72 across 76 observational studies indexed under Pulmonary Atelectasis.

Browse Pulmonary Atelectasis studies →

Lead sponsor

University Hospital Schleswig-Holstein is the lead sponsor of 163 studies on the registry; 25 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 7 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

This study specifically focuses on the EIT monitoring of preterm and term neonates, small infants and children up to the age of 7 years treated in NICU and PICU as this is the population where the need for regional lung function monitoring tools is most urgently needed to optimize the ventilator therapy, validate the effectiveness, efficacy and safety of nursing and medical interventions (endotracheal suctioning, posture changes, surfactant therapy, alveolar recruitment, etc.) and prevent/minimize the occurrence of acute (pneumothorax, endotracheal tube misplacement) and chronic (chronic lung disease or bronchopulmonary dysplasia) adverse effects.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Written, informed consent of both parents or legal representative
  • Admission in the NICU or PICU
  • Patients with or at high risk of developing respiratory failure needing respiratory support.

    o i.e. (oxygen need (FiO2>25%) AND noninvasive or invasive respiratory support) AND/OR repeated apnea with desaturations

  • Age from birth to 7 years o Initial focus will be on neonates up to 6 kg and 12 months age. Infants of higher weight up to 7 years age will be included as EIT belts for this age group become available.

Exclusion criteria

Exclusion Criteria:

  • Post menstrual age less than 25 weeks
  • Body weight \< 600 g
  • Electrically active implants
  • Thorax skin lesions
  • Prior participation for the same diagnosis of lung disease
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
200 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Change in aggregate measure of ventilation homogeneity (coefficient of variation and global inhomogeneity index of regional tidal volume) by > 10% compared with baseline

    Time frame: 72 hours

  2. Change in right-to-left and/or anteroposterior ventilation distribution by >10% compared with baseline

    Time frame: 72 hours

  3. Time and duration of right-to-left or left-to-right ventilation ratio >2:1

    Time frame: 72 hours

  4. Percentage of EIT examination time with at least 26 out of 32 sensors exhibiting skin contact impedance of < 700 Ohm

    Skin contact impedance will be monitored continuously by the EIT device. If more than 6 sensors exhibit skin contact impedance \> 700 Ohm, the examination is no longer suitable for analyzing. To assess the percentage of EIT measurements suitable for analyzing, we will calculate the percentage of EIT examination time with at least 26 out of 32 sensors exhibiting skin contact impedance of less than 700 Ohm.

    Time frame: 72 hours

Secondary outcomes

  1. Relationship between time of onset/end of non-invasive respiratory support and EIT findings

    Time frame: 72 hours

  2. Relationship between time of intubation/extubation and EIT findings

    Time frame: 72 hours

  3. Relationship between time of suctioning and EIT findings

    Time frame: 72 hours

  4. Relationship between time and type of posture change and EIT findings

    Time frame: 72 hours

  5. Relationship between time of surfactant administration and EIT findings

    Time frame: 72 hours

  6. Relationship between time of clinically indicated radiological examination and EIT findings

    Time frame: 72 hours

  7. Relationship between time of recruitment manoeuvre and EIT findings

    Time frame: 72 hours

  8. Relationship between time of confirmed pneumothorax and EIT findings

    Time frame: 72 hours

  9. Relationship between time of confirmed endotracheal tube malposition and EIT findings

    Time frame: 72 hours

  10. Relationship between primary cause of respiratory failure and EIT findings

    Time frame: 72 hours

  11. Relationship between fraction of inspired oxygen over time and EIT findings

    Time frame: 72 hours

  12. Relationship between saturation of peripheral oxygen over time and EIT findings

    Time frame: 72 hours

07

Study locations

4 sites
  • Archbishop Makarios III Hospital
    Nicosia, Cyprus
  • Oulu University Hospital
    Oulu, Finland
  • Academic Medical Center
    Amsterdam, Netherlands
  • VU University Medical Center
    Amsterdam, Netherlands
08

References and documents

Publications

  • Becher TH, Miedema M, Kallio M, Papadouri T, Karaoli C, Sophocleous L, Rahtu M, van Leuteren RW, Waldmann AD, Strodthoff C, Yerworth R, Dupre A, Benissa MR, Nordebo S, Khodadad D, Bayford R, Vliegenthart R, Rimensberger PC, van Kaam AH, Frerichs I. Prolonged Continuous Monitoring of Regional Lung Function in Infants with Respiratory Failure. Ann Am Thorac Soc. 2022 Jun;19(6):991-999. doi: 10.1513/AnnalsATS.202005-562OC. PubMed 34898392 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 21, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02962505
Collaborators
Middlesex University London, University College, London, NICU of Makarios III Hospital-The Ministry of Health for the Republic of Cyprus, Bio-Medical Research Foundation, University of Geneva, Switzerland, Linneuniversitetet, SWISSTOM AG, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Studio Fifield, Panaxea
Responsible party
Inez Frerichs (Prof. Dr. Inéz Frerichs, University Hospital Schleswig-Holstein) — Principal investigator
First posted
Nov 11, 2016
Start date
Nov 2016
Primary completion
Mar 3, 2019
Completion
Mar 3, 2019
Last update
Mar 21, 2019

Study contacts

Inez Frerichs, MD
study chair · University Medical Center SH, Kiel , Germany

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion